Kendall EA - Search Results

1

Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort study.

Kendall EA, Theron D, Franke MF, van Helden P, Victor TC, Murray MB, Warren RM, Jacobson KR. Kendall EA, et al. PLoS One. 2013 Dec 13;8(12):e83480. doi: 10.1371/journal.pone.0083480. eCollection 2013. PLoS One. 2013. PMID: 24349518 Free PMC article. Clinical Trial.

2

Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa.

Jacobson KR, Theron D, Kendall EA, Franke MF, Barnard M, van Helden PD, Victor TC, Streicher EM, Murray MB, Warren RM. Jacobson KR, et al. Among authors: kendall ea. Clin Infect Dis. 2013 Feb;56(4):503-8. doi: 10.1093/cid/cis920. Epub 2012 Oct 22. Clin Infect Dis. 2013. PMID: 23090928 Free PMC article.

3

Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.

Kendall EA, Fofana MO, Dowdy DW. Kendall EA, et al. Lancet Respir Med. 2015 Dec;3(12):963-72. doi: 10.1016/S2213-2600(15)00458-0. Epub 2015 Nov 18. Lancet Respir Med. 2015. PMID: 26597127 Free PMC article.

4

Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.

Kendall EA, Fojo AT, Dowdy DW. Kendall EA, et al. Lancet Respir Med. 2017 Mar;5(3):191-199. doi: 10.1016/S2213-2600(16)30423-4. Epub 2016 Dec 16. Lancet Respir Med. 2017. PMID: 27989591 Free PMC article.

5

MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis.

Kendall EA, Azman AS, Cobelens FG, Dowdy DW. Kendall EA, et al. PLoS One. 2017 Mar 8;12(3):e0172748. doi: 10.1371/journal.pone.0172748. eCollection 2017. PLoS One. 2017. PMID: 28273116 Free PMC article.

6

Of Testing and Treatment: Implications of Implementing New Regimens for Multidrug-Resistant Tuberculosis.

Dowdy DW, Theron G, Tornheim JA, Warren R, Kendall EA. Dowdy DW, et al. Among authors: kendall ea. Clin Infect Dis. 2017 Oct 1;65(7):1206-1211. doi: 10.1093/cid/cix486. Clin Infect Dis. 2017. PMID: 29554229 Free PMC article.

7

What will it take to eliminate drug-resistant tuberculosis?

Kendall EA, Sahu S, Pai M, Fox GJ, Varaine F, Cox H, Cegielski JP, Mabote L, Vassall A, Dowdy DW. Kendall EA, et al. Int J Tuberc Lung Dis. 2019 May 1;23(5):535-546. doi: 10.5588/ijtld.18.0217. Int J Tuberc Lung Dis. 2019. PMID: 31097060 Free PMC article.

8

Clinical Impact of Rapid Drug Susceptibility Testing to Accompany Fluoroquinolone-Containing Universal Tuberculosis Regimens: A Markov Model.

Kendall EA, Malhotra S, Cook-Scalise S, Dowdy DW, Denkinger CM. Kendall EA, et al. Clin Infect Dis. 2020 Dec 31;71(11):2889-2896. doi: 10.1093/cid/ciz1179. Clin Infect Dis. 2020. PMID: 31813958 Free PMC article.

9

A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.

Baik Y, Rickman HM, Hanrahan CF, Mmolawa L, Kitonsa PJ, Sewelana T, Nalutaaya A, Kendall EA, Lebina L, Martinson N, Katamba A, Dowdy DW. Baik Y, et al. Among authors: kendall ea. PLoS Med. 2020 Nov 10;17(11):e1003420. doi: 10.1371/journal.pmed.1003420. eCollection 2020 Nov. PLoS Med. 2020. PMID: 33170838 Free PMC article.

10

Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective.

Kendall EA, Cohen T, Mitnick CD, Dowdy DW. Kendall EA, et al. Int J Infect Dis. 2017 Mar;56:185-189. doi: 10.1016/j.ijid.2016.12.010. Epub 2016 Dec 19. Int J Infect Dis. 2017. PMID: 28007660 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page